Skip to main content

previous disabled Page of 9
and
  1. Article

    Open Access

    Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

    High-grade B-cell lymphoma (HGBCL), the subtype of non-Hodgkin lymphoma, to be relapsed or refractory in patients after initial therapy or salvage chemotherapy. Dual dysregulation of MYC and BCL2 is one of the...

    Lin Liu, Wenbin Mo, Miao Chen, Yi Qu, **** Wang, Ying Liang, **ao**g Yan in BMC Cancer (2024)

  2. Article

    Open Access

    QL1209 (pertuzumab biosimilar) versus reference pertuzumab plus trastuzumab and docetaxel in neoadjuvant treatment for HER2-positive, ER/PR-negative, early or locally advanced breast cancer: A multicenter, randomized, double-blinded, parallel-controlled, phase III equivalence trial

    This randomized, parallel-controlled, double-blinded, phase III equivalence study evaluated the equivalence of a proposed pertuzumab biosimilar QL1209 to the pertuzumab (Perjeta®) each with trastuzumab and doc...

    Wenjia Zuo, Zhonghua Wang, Jun Qian, **aopeng Ma, Zhaofeng Niu in British Journal of Cancer (2024)

  3. No Access

    Article

    NK cells as powerful therapeutic tool in cancer immunotherapy

    Natural killer (NK) cells have gained considerable attention and hold great potential for their application in tumor immunotherapy. This is mainly due to their MHC-unrestricted and pan-specific recognition cap...

    Mao Huang, Yixuan Liu, Qijia Yan, Miao Peng, Junshang Ge, Yongzhen Mo in Cellular Oncology (2024)

  4. Article

    Open Access

    Deciphering Müller cell heterogeneity signatures in diabetic retinopathy across species: an integrative single-cell analysis

    Diabetic retinopathy (DR), a leading cause of visual impairment, demands a profound comprehension of its cellular mechanisms to formulate effective therapeutic strategies. Our study presentes a comprehensive s...

    **yuan Deng, Ya Mo, **uying Zhu in European Journal of Medical Research (2024)

  5. Article

    Open Access

    Ethanol responsive lnc171 promotes migration and invasion of HCC cells via mir-873-5p/ZEB1 axis

    Long nonconding RNAs (lncRNAs) have been found to be a vital regulatory factor in the development process of human cancer, and could regarded as diagnostic or prognostic biomarkers for human cancers. Here, we ...

    Shi** Huang, Zhouxiang Liao, **ao He, Zhenyu Song, ** Fang, Sha Wen in BMC Cancer (2024)

  6. Article

    Open Access

    Association of serum 25-hydroxy-vitamin D concentration and risk of mortality in cancer survivors in the United States

    Cancer survivors have a high risk of mortality, and vitamin D (VD) is associated with the risk of mortality. This study is aim to examine the impact of VD on mortality in cancer survivors.

    **aofei Mo, Chen He, Fengfeng Han, Hui Yan, Xueqin Chen, Yuetao Wang in BMC Cancer (2024)

  7. Article

    Open Access

    Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer

    Aberrant expressions of desmoglein 2 (Dsg2) and desmocollin 2(Dsc2), the two most widely distributed desmosomal cadherins, have been found to play various roles in cancer in a context-dependent manner. Their s...

    Ji-Yuan Han, Na Che, **g Mo, Dan-Fang Zhang, **ao-Hui Liang, Xue-Yi Dong in BMC Cancer (2024)

  8. Article

    Open Access

    Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia

    Liangliang Wu, Limin Liu, **n Zhao, Ming Zhou, Andie Fu in Blood Cancer Journal (2024)

  9. Article

    Open Access

    Tibial cortex transverse transport promotes ischemic diabetic foot ulcer healing via enhanced angiogenesis and inflammation modulation in a novel rat model

    Tibial Cortex Transverse Transport (TTT) represents an innovative surgical method for treating lower extremity diabetic foot ulcers (DFUs), yet its underlying mechanisms remain elusive. Establishing an animal ...

    Wencong Qin, Kaibin Liu, Hongjie Su, Jun Hou in European Journal of Medical Research (2024)

  10. Article

    Open Access

    Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets

    Traditional nanodrug delivery systems have some limitations, such as eliciting immune responses and inaccuracy in targeting tumor microenvironments.

    Xuanbo Da, Bang** Cao, Jiantao Mo, Yukai **ang, Hai Hu, Chen Qiu in BMC Cancer (2024)

  11. Article

    Open Access

    Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with recurrent glioblastoma

    There are limited and no standard therapies for recurrent glioblastoma. We herein report the antitumour activity and safety of sintilimab, bevacizumab and temozolomide (TMZ) in recurrent glioblastoma.

    Yinghao Lu, Limin Liao, Kunpeng Du, Jianhua Mo, **a Zou, Junxian Liang in BMC Cancer (2024)

  12. Article

    Open Access

    MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study

    Yang Cao, Wenxuan Huo, Jiayu Huang, Yang Yang, Yu Wang in Blood Cancer Journal (2024)

  13. Article

    Open Access

    Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial

    Supraclavicular nodal (SCL) irradiation is commonly used for patients with high-risk breast cancer after breast surgery. The Radiation Therapy Oncology Group (RTOG) and European Society for Radiotherapy and On...

    Li Zhang, **n Mei, Zhigang Hu, Bo Yu, Chaoyang Zhang, Yong Li, Kaitai Liu in BMC Cancer (2024)

  14. Article

    Open Access

    Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy

    The role of circulating tumor cells (CTCs) in prognosis prediction has been actively studied in hepatocellular carcinoma (HCC) patients. However, their efficiency in accurately predicting early progression rec...

    Zhan Lu, Hanghang Ni, **hua Yang, Lihao Tan, Haixiao Zhuang, Yunning Mo in BMC Cancer (2023)

  15. No Access

    Article

    Dual PI3K/HDAC Inhibitor BEBT-908 Exhibits Potent Efficacy as Monotherapy for Primary Central Nervous System Lymphoma

    The efficacy of systemic treatment for primary central nervous system lymphoma (PCNSL) is limited because of the blood–brain barrier (BBB) and the ineffectiveness of chemotherapy. The dual PI3K/HDAC inhibitor ...

    Ning Wang, Zhenxian Mo, Lu Pan, Minhua Zhou, **aolan Ye, **njian Liu in Targeted Oncology (2023)

  16. Article

    Open Access

    The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer

    Although the current European Association of Urology(EAU) guideline recommends that patients with intermediate-risk non-muscle-invasive bladder cancer (NMIBC) should accept intravesical chemotherapy or Calmett...

    Jian-**n Chen, Wen-Ting Huang, Qing-Yun Zhang, Cheng-En Deng, Jue-ling Wei in BMC Cancer (2023)

  17. No Access

    Article

    Aberrant expression of circular RNA DHPR facilitates tumor growth and metastasis by regulating the RASGEF1B/RAS/MAPK axis in hepatocellular carcinoma

    Circular RNAs (circRNAs) are noncoding RNAs. Accumulating evidence suggests that circRNAs play a critical role in human biological processes, especially tumorigenesis, and development. However, the exact mecha...

    Zeyi Guo, Qingyu **e, Yan** Wu, Haiyu Mo, Jiajun Zhang, Guolin He in Cellular Oncology (2023)

  18. Article

    Open Access

    Analysis of m7G-Related signatures in the tumour immune microenvironment and identification of clinical prognostic regulators in breast cancer

    Breast cancer is a malignant tumour that seriously threatens women’s life and health and exhibits high inter-individual heterogeneity, emphasising the need for more in-depth research on its pathogenesis. While...

    Qinghua Huang, Jianlan Mo, Huawei Yang, Yinan Ji, Rong Huang, Yan Liu in BMC Cancer (2023)

  19. Article

    Open Access

    Integrative molecular subtypes of acute myeloid leukemia

    Qianxing Mo, Seongseok Yun, David A. Sallman, Nicole D. Vincelette in Blood Cancer Journal (2023)

  20. No Access

    Article

    Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation

    Cerebral cavernous malformations (CCMs) refer to a common vascular abnormality that affects up to 0.5% of the population. A somatic gain-of-function mutation in MAP3K3 (p.I441M) was recently reported in sporadic ...

    Ran Huo, Yingxi Yang, Yingfan Sun, Qiuxia Zhou, Shaozhi Zhao, Zongchao Mo in Angiogenesis (2023)

previous disabled Page of 9